Archives: Speakers

Frank Engel started at Rousselot in 2018 and holds a Bsc. in Health Sciences and a Msc. in Health Food Innovation Management. Frank is based in Rousselot’s headquarter in Son, the Netherlands and in his role he is in close contact with R&D, application lab and quality department as well as commercial and technical support teams in all Rousselot’s 6 sales regions.

Dr. Suso Platero leads the Biomarker Solution Center, providing clients with biomarker consultation and strategy that leverages both Covance and LabCorp laboratories resources to aid in the development of biomarker delivery. He draws on 20+ years of experience with contract research organizations, diagnostic and pharmaceutical industries and academia, as well as with federal agencies and key opinion leaders in oncology and immuno-oncology.

Dr. Platero has contributed to the discovery of biomarkers and their application in clinical trials as well as the development of biomarkers to support companion diagnostics (CDx) and recently helped develop a companion diagnostic for a drug that was approved by the FDA in 2019. He served as the editor of the book, Molecular Pathology in Drug Discovery and Development, has authored numerous articles and holds four U.S. patents.

Oliver Cunningham is the Senior Director of Product Management at Signant Health, providing professional services to pharmaceutical/biotech R&D organizations and driving product innovation in support of Signant Health’s IRT and supply chain technologies. Prior to joining Signant Health in 2017, Oliver spent 14 years at AstraZeneca, holding scientific and supply chain management positions. He is an expert in supply chain management and has held various roles in global planning, clinical supplies and leading early development technical teams. As the Clinical Supply Chain Optimization lead at AstraZeneca, Oliver was responsible for delivering clinical supply chains across all phases of development, including the Fulvestrant and Lynparza programs. Oliver has a Masters in Chemistry with Industrial Chemistry from the University of Liverpool.

Tom has over 10 years experience in FMCG across a breadth of categories. Most recently though, he and a team of like-minded entrepreneurs, product scientists and brand builders grouped together to form OTO International Ltd. OTO, which translates as ‘sound’ in Japanese, aims to help people discover the amazing power of CBD through thoughtful and effective products that easily and enjoyably fit into our daily lives. Tom has been spear-heading OTO’s growth into new territories and is looking at continued ways to ensure OTO remains the thought, brand and market leader in this growing space.

My name is Joseph Zhou. I am the founder of Hongzhi Medical Device Technical Co., Ltd. I bought Cardiosignal GmbH in Dec 2018. Now we are applying for CFDA and CE for our latest Mechanical Heart Valve Monitor. We are doing research for our new device Heart Failure Monitor. What’s more, we will doing research for Artificial Heart Monitor. All 3 household devices are very small and easily used. We focus on developing new cardiology household medical devices.